Eaton Vance Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $331M | Buy |
3,848,802
+24,866
| +0.7% | +$2.22M | 0.49% | 39 |
|
|
2022
Q2 | $349M | Buy |
3,823,936
+76,341
| +2% | +$6.77M | 0.49% | 42 |
|
|
2022
Q1 | $307M | Buy |
3,747,595
+781,980
| +26% | +$61.7M | 0.35% | 56 |
|
|
2021
Q4 | $227M | Buy |
2,965,615
+39,983
| +1% | +$3.18M | 0.28% | 70 |
|
|
2021
Q3 | $216M | Sell |
2,925,632
-337,451
| -10% | -$25.7M | 0.3% | 71 |
|
|
2021
Q2 | $254M | Sell |
3,263,083
-201,565
| -6% | -$15M | 0.34% | 60 |
|
|
2021
Q1 | $255M | Sell |
3,464,648
-358,190
| -9% | -$26.4M | 0.38% | 57 |
|
|
2020
Q4 | $298M | Sell |
3,822,838
-804,444
| -17% | -$61.5M | 0.47% | 40 |
|
|
2020
Q3 | $366M | Buy |
4,627,282
+411,053
| +10% | +$32.2M | 0.67% | 31 |
|
|
2020
Q2 | $311M | Sell |
4,216,229
-58,049
| -1% | -$4.37M | 0.63% | 32 |
|
|
2020
Q1 | $314M | Sell |
4,274,278
-1,265,292
| -23% | -$99.4M | 0.76% | 27 |
|
|
2019
Q4 | $481M | Buy |
5,539,570
+170,538
| +3% | +$14M | 0.94% | 19 |
|
|
2019
Q3 | $431M | Buy |
5,369,032
+421,224
| +9% | +$33.8M | 0.93% | 21 |
|
|
2019
Q2 | $396M | Sell |
4,947,808
-848,933
| -15% | -$65M | 0.87% | 22 |
|
|
2019
Q1 | $460M | Sell |
5,796,741
-105,150
| -2% | -$7.86M | 1.06% | 17 |
|
|
2018
Q4 | $430M | Buy |
5,901,891
+755,530
| +15% | +$53.3M | 1.12% | 15 |
|
|
2018
Q3 | $348M | Buy |
5,146,361
+638,333
| +14% | +$40.7M | 0.77% | 23 |
|
|
2018
Q2 | $261M | Sell |
4,508,028
-1,070,637
| -19% | -$60.4M | 0.62% | 32 |
|
|
2018
Q1 | $290M | Buy |
5,578,665
+2,762,647
| +98% | +$149M | 0.36% | 83 |
|
|
2017
Q4 | $151M | Buy |
2,816,018
+172,544
| +7% | +$9.57M | 0.37% | 77 |
|
|
2017
Q3 | $162M | Buy |
2,643,474
+21,658
| +0.8% | +$1.31M | 0.42% | 68 |
|
|
2017
Q2 | $160M | Buy |
2,621,816
+7,204
| +0.3% | +$439K | 0.42% | 68 |
|
|
2017
Q1 | $159M | Sell |
2,614,612
-113,963
| -4% | -$6.91M | 0.43% | 69 |
|
|
2016
Q4 | $153M | Buy |
2,728,575
+8,494
| +0.3% | +$497K | 0.43% | 67 |
|
|
2016
Q3 | $162M | Sell |
2,720,081
-302,928
| -10% | -$17.7M | 0.47% | 61 |
|
|
2016
Q2 | $166M | Buy |
3,023,009
+476,210
| +19% | +$25.3M | 0.48% | 60 |
|
|
2016
Q1 | $129M | Sell |
2,546,799
-458,503
| -15% | -$22.5M | 0.4% | 75 |
|
|
2015
Q4 | $151M | Sell |
3,005,302
-5,508,188
| -65% | -$278M | 0.45% | 66 |
|
|
2015
Q3 | $401M | Buy |
8,513,490
+101,607
| +1% | +$5.4M | 1.24% | 18 |
|
|
2015
Q2 | $457M | Sell |
8,411,883
-446,039
| -5% | -$25M | 1.4% | 13 |
|
|
2015
Q1 | $486M | Sell |
8,857,922
-1,109,596
| -11% | -$62.8M | 1.46% | 9 |
|
|
2014
Q4 | $540M | Sell |
9,967,518
-162,713
| -2% | -$9.07M | 1.59% | 8 |
|
|
2014
Q3 | $573M | Buy |
10,130,231
+296,583
| +3% | +$16.7M | 1.71% | 5 |
|
|
2014
Q2 | $543M | Buy |
9,833,648
+362,306
| +4% | +$19.8M | 1.6% | 7 |
|
|
2014
Q1 | $513M | Sell |
9,471,342
-609,985
| -6% | -$31.6M | 1.51% | 10 |
|
|
2013
Q4 | $481M | Buy |
10,081,327
+766,079
| +8% | +$35M | 1.38% | 14 |
|
|
2013
Q3 | $423M | Buy |
9,315,248
+738,396
| +9% | +$33.7M | 1.27% | 15 |
|
|
2013
Q2 | $380M | Buy |
+8,576,852
| New | +$383M | 1.15% | 19 |
|
Other funds holding MRK
Eaton Vance Management's MRK Position: Q3 2022 in Review
Eaton Vance Management increased its Merck (MRK) stake by 0.65% in Q3 2022, buying an estimated $2.22M and bringing the position to 3,848,802 shares worth $331M. The position accounts for 0.49% of the portfolio, ranked #39.
Eaton Vance Management first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $573M in Q3 2014. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Eaton Vance Management held 3,848,802 shares of Merck worth $331M as of Q3 2022.
- Eaton Vance Management bought 24,866 Merck shares in Q3 2022, an estimated $2.22M.
- Merck made up 0.49% of Eaton Vance Management's portfolio in Q3 2022, its #39 holding.
- Eaton Vance Management first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- Eaton Vance Management's Merck position peaked at $573M in Q3 2014.
- 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.